+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aerie Pharmaceuticals - logo

Aerie Pharmaceuticals is a company that focuses on the development and commercialization of therapies for the treatment of glaucoma and other eye diseases. The National Eye Institute expects the number of people in the United States suffering from glaucoma to reach 4.3 million by 2030. Aerie was founded in 2005 and went in public in 2013, raising $67 million in its IPO. Its product candidates include Rhopressa and Roclatan. The company is headquartered in Irvine, California.

Collaboration Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 850 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 1200 Pages
  • Global
From
From
Controlled Release Drug Delivery Market Report 2026 - Product Thumbnail Image

Controlled Release Drug Delivery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Angina Pectoris Drugs Market Report 2026 - Product Thumbnail Image

Angina Pectoris Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Netarsudil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Netarsudil Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Loading Indicator